| Literature DB >> 34123530 |
Scott W Cheatham1, Russell T Baker2, Thomas E Abdenour3.
Abstract
BACKGROUND: The existing body of kinesiology tape (KT) research reveals inconsistent results which challenges the efficacy of the intervention. Understanding professional beliefs and KT clinical application might provide insight for future research and development of evidence-based guidelines.Entities:
Keywords: muscle soreness; perceived pain; recovery
Year: 2021 PMID: 34123530 PMCID: PMC8169012 DOI: 10.26603/001c.22136
Source DB: PubMed Journal: Int J Sports Phys Ther ISSN: 2159-2896
Table 1: Respondent demographics (Total N=1083)
|
|
|
| Male | 45.43% (492) |
| Female | 53.92% (584) |
| Other | 0.18% (002) |
| Prefer not to answer | 0.47% (005) |
|
| |
| Physical Therapist | 60.66% (657) |
| Chiropractor | 01.75% (19) |
| Certified Athletic Trainer | 30.00% (325) |
| Occupational Therapist | 0.28% (3) |
| Acupuncturist | 0.00% (0) |
| Physical Therapist Assistant | 4.09% (44) |
| Occupational Therapist Assistant | 0.09% (1) |
| Massage Therapist | 0.92% (10) |
| Certified Personal Trainer | 0.28% (3) |
| Kinesiotherapist | 0.09% (1) |
| Exercise Physiologist | 0.18% (2) |
| Educator (secondary schools, collegiate) | 0.28% (3) |
| Physician Assistant | 0.18% (2) |
| Medical Doctor, Podiatrist, Doctor of Osteopathy | 0.28% (3) |
| Other profession not listed | 0.92% (10) |
|
| |
| Private outpatient facility | 42.10% (456) |
| Public outpatient facility (e.g. state, county) | 1.48% (16) |
| Hospital based facility | 18.19% (197) |
| University/college sports medicine or athletic training facility | 12.09% (131) |
| Secondary school athletic training facility | 11.54% (125) |
| Academic/research institution | 2.22% (24) |
| Fitness or wellness facility | 1.01% (11) |
| Massage therapy facility | 0.28% (3) |
| Military service facility | 1.48% (16) |
| In-home services | 1.57% (17) |
| Professional sports | 2.59% (28) |
| Skilled nursing facility/acute facility | 0.74% (8) |
| Industrial/occupational health services | 1.94% (21) |
| Other setting not listed | 2.77% (30) |
|
| |
| Average years in professional practice | 16.13 ±11.11 years |
Table 2: Clinical perceptions about KT (N=1083)
|
| |
| Performance enhancement | 20.78% (225) |
| Injury prevention | 15.42% (167) |
| Post-injury treatment (e.g. edema, ecchymosis) | 74.24% (804) |
| Pain modulation | 66.85% (724) |
| Neuro-sensory feedback (e.g. proprioception) | 60.30% (653) |
| Myofascial mobility | 24.01% (260) |
| Neuromuscular re-education | 45.52% (493) |
| Pre-exercise warm-up | 1.39% (15) |
| Post-exercise treatment | 6.00% (65) |
| Placebo effect | 40.44% (438) |
| Posture feedback | 0.64% (7) |
| Patient requests KT | 1.38% (15) |
| Joint support | 0.46% (5) |
| Edema or swelling | 0.74% (8) |
| Other | 7.01% (76) |
|
| |
| Peer reviewed research articles, textbooks | 53.55% (580) |
| Continuing education courses or conferences | 74.33% (805) |
| Manufacturer instructions | 28.90% (313) |
| KT textbooks | 0.83% (9) |
| Websites, social media posts, or videos (e.g. YouTube) | 31.10% (338) |
| Collaboration with other professionals | 74.98% (812) |
| My prior empirical experience | 64.08% (694) |
| Patient interest | 1.66% (18) |
| Other variables not listed | 5.36% (20) |
|
| |
| Enhanced myofascial mobility | 29.46% (319) |
| Pain modulation | 69.80% (756) |
| Increased joint ROM | 15.05% (163) |
| Enhanced stretch tolerance of muscles | 13.48% (146) |
| Enhanced post-exercise recovery | 12.56% (136) |
| Enhanced pre-exercise neuromyofascial excitation | 13.11% (142) |
| Enhanced proprioception and kinesthetic sense | 69.10% (748) |
| Enhance muscle activation/motor control | 0.64% (7) |
| Inhibit muscle activation/motor control | 0.28% (3) |
| Increases in local circulation (e.g. lymphatic) | 65.47% (709) |
| Decreased edema, swelling, and/or effusion | 0.28% (3) |
| Postural awareness | 0.18% (2) |
| Placebo effect | 58.63% (635) |
| Other effects not listed | 3.23% (35) |
|
| |
| Tape lifts the skin to allow improved local circulation | 69.16% (749) |
| Tape stimulates skin mechanoreceptors increasing proprioception | 77.00% (834) |
| Tape stimulates skin nociceptors resulting in pain modulation | 60.20% (652) |
| Tape help improve joint range of motion | 15.24% (165) |
| Tape helps improve muscle performance (strength) | 13.85% (150) |
| Tape helps improve muscle activation and motor control | 46.26% (501) |
| Tape can inhibit muscle activation | 31.86% (345) |
| Tape can create a placebo effect | 73.68% (798) |
| Other physiological mechanisms not listed | 1.38% (15) |
|
| |
| Enhanced myofascial mobility | 23.45% (254) |
| Pain modulation | 55.31% (599) |
| Increased joint ROM | 9.42% (102) |
| Enhanced stretch tolerance of muscles | 10.80% (117) |
| Enhanced post-exercise recovery | 6.74% (73) |
| Enhanced pre-exercise neuromyofascial excitation | 10.06% (109) |
| Enhanced proprioception and kinesthetic sense | 58.73% (636) |
| Increases in local circulation (e.g. lymphatic) | 43.31% (469) |
| Placebo effect | 43.86% (475) |
| Joint stability | 0.83% (9) |
| Muscle inhibition | 0.18% (2) |
| Other effects not listed | 1.01% (11) |
|
| |
| Skin reaction/allergy (e.g. irritation, itching) | 50.69% (549) |
| Thin skin (e.g. common in elderly) | 25.48% (276) |
| Lymph node removal | 2.86% (31) |
| Connective tissue disorder (e.g. Marfan syndrome) | 3.79% (41) |
| Medications that alter sensation | 1.57% (17) |
| Pregnancy | 1.39% (15) |
| impaired or altered sensation | 9.08% (87) |
| Unusual pain or discomfort | 6.19% (67) |
|
| |
| No other precautions | 94.92% (1,028) |
| Prior skin reaction to KT | 0.74% (8) |
| Allergy to adhesives or latex | 0.74% (8) |
| Patient understanding, compliance, and self-efficacy | 1.01% (11) |
| Patient ability to self-apply tape | 0.37% (4) |
| Patients with impaired judgement/cognition | 0.65% (7) |
| Other reason not listed above | 1.57% (17) |
|
| |
| Diabetes | 2.40% (26) |
| Peripheral neuropathy | 1.39% (15) |
| Acute injury | 1.57% (17) |
| Skin with open wounds or lesions | 32.87% (356) |
| Allergy to adhesives, latex, or synthetic tapes | 33.33% (361) |
| Deep vein thrombosis | 4.80% (52) |
| Congestive heart failure | 1.66% (18) |
| Malignancy (active) | 3.51% (38) |
| Renal insufficiency | 0.28% (3) |
| Infection or fever | 1.85% (20) |
| Undiagnosed rash or skin irritation | 3.69% (40) |
| Inability to communicate | 13.48% (146) |
| Lymph edema | 0.55% (6) |
|
| |
| No other contraindications | 84.76% (918) |
| Patient willingness, mental status, or dependence | 1.11% (12) |
| Inability to reach a body region | 0.74% (8) |
| Skin sensitivity or tolerance | 1.66% (18) |
| Fragile or thin skin | 1.94% (21) |
| Other contraindications not listed | 9.79 (106) |
* Respondents chose all options that applied to them; **Respondents ranked their answers; ***Respondents provided answers in a comment section; KT= kinesiology tape; ROM=range of motion
Table 3: Clinical application of standard and specialty KT (N=1083)
|
| |
| KT Tape | 59.10% (640) |
| RockTape | 50.41% (546) |
| Kinesio Tex | 33.15% (359) |
| P-Tex | 0.37% (4) |
| TheraBand | 10.71% (116) |
| Spider Tech | 3.42% (37) |
| Strength Tape | 1.02% (11) |
| Mueller | 7.39% (80) |
| Dynamic | 3.41% (37) |
| Levotape | 0.83% (9) |
| Leukotape | 0.18% (2) |
| Other brands not listed | 9.04% (98) |
|
| |
| Black | 71.47% (774) |
| Beige | 65.83% (713) |
| Blue | 30.66% (332) |
| Pink | 17.63% (191) |
| Green | 2.68% (29) |
| Purple | 4.80% (52) |
| Red | 7.94% (86) |
| Yellow | 0.46% (5) |
| Orange | 0.37% (4) |
| Skin tone | 0.46% (5) |
| White | 0.27% (3) |
|
| |
| Pre-cut strips (2 in x 10 in) (5 cm x 25 cm) | 15.51% (168) |
| Pre-cut strips (4 in x 10 in) (10 cm x 25 cm) | 3.05% (33) |
| Pre-cut strips for digits (1 in x 10 in) (2.54 cm x 25 cm) | 0.37% (4) |
| Uncut roll (2 in x 16.4 ft) (5 cm x 5 m) | 66.85% (724) |
| Uncut roll (3 in x 16.4 ft) (7.5 cm x 5 m) | 10.53% (114) |
| Uncut roll (4 in x 16.4 ft) (10 cm x 5 m) | 6.19% (67) |
| Uncut roll for digits (1 in x 16.4 ft) (2.5 cm x 5 m) | 0.74% (8) |
| Uncut large roll (2 in x 105 ft) (5 cm x 32 m) | 35.92% (389) |
| Uncut large roll (4 in x 105 ft) (10 cm x 32 m) | 4.71% (51) |
|
| |
| Blister prevention tape | 0.92% (10) |
| Pre-cut fan tape (e.g. edema, bruising, lymphatic drainage) | 8.86% (96) |
| Pre-cut X tape | 2.03% (22) |
| Pre-cut tape for the upper body regions | 3.51% (38) |
| Pre-cut tape for the lower body regions | 3.97% (43) |
| I do not use specialty pre-cut tape | 83.28% (902) |
| I cut my own tape | 0.37% (4) |
|
| |
| 25% tension | 24.75% (268) |
| 50% tension | 47.09% (510) |
| 75% tension | 18.37% (199) |
| 100% tension | 2.12% (23) |
| 125% tension | 0.74% (8) |
| 150% tension | 0.28% (3) |
| 175% tension | 0.09% (1) |
| No tension | 6.56% (71) |
* Respondents chose all options that applied to them; KT= kinesiology tape
Table 4: Clinical application of Infused KT, topicals, and clinical measures (N=1083)
|
| |
| Tape infused with CBD (Hemp) | 0.18% (2) |
| Tape infused with Menthol | 0.28% (3) |
| Tape infused with Copper | 0.18% (2) |
| Tape infused with Tourmaline | 0.09% (1) |
| I do not use infused tape | 99.54% (1078) |
|
| |
| Biofreeze | 23.55% (255) |
| Tiger Balm | 3.51% (38) |
| Flexall | 5.63% (61) |
| RockSauce Fire | 9.05% (98) |
| RockSauce Ice | 7.11% (77) |
| Solonpas | 1.29% (14) |
| IcyHot | 1.39% (15) |
| Mineral Ice | 0.18% (2) |
| Ben Gay | 0.18% (2) |
| CBD Topical | 2.22% (24) |
| Cramer Atomic Balm | 1.75% (19) |
| Arnica | 3.60% (39) |
| Voltaren Gel | 5.08% (55) |
| Hydro cortisone | 0.92% (10) |
| Sombra | 1.75% (19) |
| Other brands not listed | 3.51% (38) |
| I do not use any topical analgesic | 65.00% (704) |
|
| |
| Joint range of motion (e.g. goniometer, inclinometer) | 40.17% (435) |
| Pressure pain threshold (e.g. algometer) | 17.08% (185) |
| Patient reported outcomes (e.g. NRS, VAS pain scales) | 79.59% (862) |
| Movement based testing (e.g. FMS, SFMA) | 36.29% (393) |
| Muscle performance (strength) testing | 31.12% (337) |
| Activity or sports specific assessment | 40.35% (437) |
| Girth measurements (e.g. edema) | 42.75% (463) |
| Gait assessment | 0.55% (6) |
| Palpation | 0.37% (4) |
| Observation/visual changes | 0.65% (7) |
| Other measures not listed | 0.92% (10) |
| I do not use clinical measures to assess the effects of KT | 11.08% (120) |
* Respondents chose all options that applied to them; KT= kinesiology tape; CBD: Cannabidiol
Table 5: KT education and referral (N=1083)
|
| |
| Yes | 64.17% (695) |
| No | 35.83% (388) |
|
| |
| Clean and dry skin (e.g. soap/water, isopropyl alcohol) | 53.18% (576) |
| Avoid lotions, oils, topicals, or gels | 36.56% (396) |
| Trim or remove hair in body region | 12.10% (131) |
| Inspect skin integrity, rashes, open wounds, etc. | 1.10% (12) |
|
| |
| Yes | 77.29% (837) |
| No | 22.71% (246) |
|
| |
| Wet tape before removal | 10.44% (113) |
| Remove tape slowly | 43.77% (474) |
| Remove tape slowly and pull skin in opposite direction | 1.75% (19) |
| Remove tape in the direction of hair growth | 5.35% (58) |
| Remove tape parallel to skin | 2.21% (24) |
| Apply oil (baby, mineral) to tape, or use adhesive remover | 17.64% (191) |
| Do not rip off tape | 6.19% (67) |
|
| |
| Less than One Day | 2.40% (26) |
| One Day | 8.59% (93) |
| Two Days | 31.76% (344) |
| Three Days | 37.49% (406) |
| Four Days | 8.03% (87) |
| Five Days | 4.06% (44) |
| Greater than 5 days | 1.57% (17) |
| I do not recommend | 6.09% (66) |
|
| |
| Less than One Day | 1.11% (12) |
| One Day | 3.14% (34) |
| Two Days | 10.53% (114) |
| Three Days | 23.92% (259) |
| Four Days | 12.93% (140) |
| Five Days | 32.96% (357) |
| Greater than 5 days | 5.82% (63) |
| I do not recommend | 9.60% (104) |
|
| |
| Live instruction | 88.64% (960) |
| Video instruction | 3.14% (34) |
| Self-guided program (e.g. client chooses parameters) | 3.97% (43) |
| Education materials (e.g. handouts with exercises) | 4.25% (46) |
|
| |
| Manufacturer website | 25.58% (277) |
| Generic websites (e.g. Amazon) | 65.00% (704) |
| Retail Store (brick and mortar) | 43.30% (469) |
| Sell in my facility | 16.90% (183) |
| Provide it free to patients | 1.57% (17) |
| Commercial distributor/medical supply | 0.28% (3) |
| I don't recommend | 23.82% (258) |
| Other recommendations not listed | 5.82% (6) |
* Respondents provided answers in a comment section; **Respondents ranked their answers; **Respondents chose all options that applied to them